Torray LLCHALO history

Issuer:
Halozyme Therapeutics
Quarters tracked:
39 (Q4 2016Q2 2026)
Current shares:
38,703
Current value:
$3.03M
Peak shares:
60,119 (Q4 2016)
Overall change:
-36%
QuarterSharesValue$/ShareShare ΔΔ%
Q2 202638,703$3.03M$78.26+524+1%
Q1 202638,179$2.47M$64.64+440%
Q4 202538,135$2.57M$67.29+140%
Q3 202538,121$2.80M$73.35-1,927-5%
Q2 202540,048$2.08M$52.01-15,336-28%
Q1 202555,384$3.53M$63.81-2270%
Q4 202455,611$2.66M$47.81+353+1%
Q3 202455,258$3.16M$57.24+4,510+9%
Q2 202450,748$2.66M$52.36+3,175+7%
Q1 202447,573$1.94M$40.67+7,687+19%
Q4 202339,886$1.47M$36.96+13,881+53%
Q3 202326,005$993K$38.18+1,046+4%
Q2 202324,959$900K$36.06+245+1%
Q1 202324,714$944K$38.20-6,781-22%
Q4 202231,495$1.79M$56.90-1,418-4%
Q3 202232,913$1.30M$39.53+4,620+16%
Q2 202228,293$1.25M$44.00-9,527-25%
Q1 202237,820$1.51M$39.87+1,970+5%
Q4 202135,850$1.44M$40.22-10,819-23%
Q3 202146,669$1.90M$40.67+583+1%
Q2 202146,086$2.09M$45.42-488-1%
Q1 202146,574$1.94M$41.70-652-1%
Q4 202047,226$2.02M$42.71+476+1%
Q3 202046,750$1.23M$26.29-324-1%
Q2 202047,074$1.26M$26.81-4,999-10%
Q1 202052,073$937K$17.99+2410%
Q4 201951,832$919K$17.73+5,479+12%
Q3 201946,353$719K$15.51+1100%
Q2 201946,243$794K$17.17-5,584-11%
Q1 201951,827$834K$16.0900%
Q4 201851,827$758K$14.63+7,951+18%
Q3 201843,876$797K$18.16+6,324+17%
Q2 201837,552$634K$16.88-1,488-4%
Q1 201839,040$765K$19.60+452+1%
Q4 201738,588$782K$20.27+8,643+29%
Q3 201729,945$520K$17.37+258+1%
Q2 201729,687$381K$12.83-1,099-4%
Q1 201730,786$399K$12.96-29,333-49%
Q4 201660,119$594K$9.88NEW